Beta-blockers to prevent heart rhythm issues after PFO closure
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests if a beta-blocker can prevent short-term heart rhythm problems after a procedure to close a hole in the heart (PFO). If you are scheduled for PFO closure with a specific device, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You are scheduled to have your PFO closed with a Cocoon device
- You have not had atrial fibrillation or other atrial rhythm problems in the past
- You do not have uncontrolled asthma or COPD
- You have no history of heart failure, severe valve disease, or weak heart pump
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well patients do over time after having a hole in their heart (patent foramen ovale, or PFO) closed with a small device inserted through a vein. It may help doctors understand the benefits and risks of the procedure.
This trial tests a new, dissolvable device to close a hole in the heart called a PFO. It may help people who have had a stroke or mini-stroke linked to this hole.
This trial tests a new device to close a PFO (a small hole between the upper chambers of the heart) in people who have had a stroke caused by a blood clot. The goal is to prevent future strokes by blocking the hole.
This study looks at whether closing a small hole in the heart (called a PFO) can cause new heart rhythm problems. It is for people who had a stroke caused by a PFO and are planning to have it closed.
This trial tests a new stitch system to close a small hole in the heart called PFO, which can cause strokes. It is for people who have had a stroke or mini-stroke linked to this hole.
This trial tests a new device to close a PFO (a small hole in the heart) in people who have had a stroke caused by a blood clot passing through that hole. The goal is to see if the device can prevent another stroke.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.